Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-03 Sale |
2023-04-04 5:03 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
6,700 | $3.691 | $24,730 | 796,366 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 5:04 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
7,000 | $3.4243 | $23,970 | 806,681 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 5:08 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
7,700 | $3.7923 | $29,201 | 928,681 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-04 7:30 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
6,970 | $3.1759 | $22,136 | 751,913 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-05 4:35 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,400 | $3.9089 | $36,744 | 761,151 (Direct) |
View |
| 2022-10-03 Sale(A) |
2022-11-23 5:01 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,500 | $3.9061 | $37,108 | 1,570,002 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:49 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,700 | $4.0263 | $39,055 | 765,059 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-31 Tax Withholding |
2023-04-04 5:03 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
3,615 | $3.9 | 796,366 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:02 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | GRAINGER DAVID J Chief Innovation Officer |
4,825 | $3.9 | 1,003,980 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:01 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Quality Officer |
4,319 | $3.9 | 165,102 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:14 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer |
150,400 | $0 | 282,347 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:13 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel |
167,100 | $0 | 320,159 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:11 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | GRAINGER DAVID J Chief Innovation Officer |
192,200 | $0 | 1,123,805 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:10 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
526,400 | $0 | 1,270,375 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:09 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Financial Officer |
192,200 | $0 | 415,615 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:08 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
192,200 | $0 | 928,681 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:06 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Quality Officer |
75,200 | $0 | 214,421 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:05 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | CHAO DAVID M Chief Administrative Officer |
192,200 | $0 | 408,600 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:04 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer |
133,700 | $0 | 133,700 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:47 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer |
5,382 | $4.25 | 134,868 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:46 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | GRAINGER DAVID J Chief Innovation Officer |
7,154 | $4.25 | 934,102 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:44 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | CHAO DAVID M Chief Administrative Officer |
9,211 | $4.25 | 221,289 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:42 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel |
11,445 | $4.25 | 157,055 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:41 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Financial Officer |
11,282 | $4.25 | 228,718 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:40 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
7,732 | $4.25 | 782,019 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2023-01-13 5:38 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Quality Officer |
5,765 | $4.25 | 142,235 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:30 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
2,268 | $3.1 | 751,913 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:28 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Financial Officer |
5,303 | $3.1 | 234,697 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:26 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer |
2,921 | $3.1 | 137,329 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:25 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
44,025 | $3.1 | 743,975 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:23 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel |
3,996 | $3.1 | 164,504 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:20 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | GRAINGER DAVID J Chief Innovation Officer |
2,497 | $3.1 | 938,759 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:18 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | CHAO DAVID M Chief Administrative Officer |
4,889 | $3.1 | 225,611 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:17 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Quality Officer |
3,014 | $3.1 | 144,986 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-05 4:42 pm |
N/A 2032-12-01 |
Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer |
300,000 | $0 | 300,000 (Direct) |
View |